-
1
-
-
0034964207
-
Physiological and molecular basis of thyroid hormone action
-
Yen PM: Physiological and molecular basis of thyroid hormone action. Physiol Rev 81: 1097-1142, 2001
-
(2001)
Physiol Rev
, vol.81
, pp. 1097-1142
-
-
Yen, P.M.1
-
2
-
-
33749431724
-
Deiodinases: Implications of the local control of thyroid hormone action
-
Bianco AC, Kim BW: Deiodinases: Implications of the local control of thyroid hormone action. J Clin Invest 116: 2571-2579, 2006
-
(2006)
J Clin Invest
, vol.116
, pp. 2571-2579
-
-
Bianco, A.C.1
Kim, B.W.2
-
3
-
-
0030051476
-
Thyroid hormone metabolism and thyroid diseases in chronic renal failure
-
Kaptein EM: Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 17: 45-63, 1996
-
(1996)
Endocr Rev
, vol.17
, pp. 45-63
-
-
Kaptein, E.M.1
-
4
-
-
0017150047
-
Abnormal TSH, PRL and GH response to TSH releasing factor in chronic renal failure
-
Czernichow P, Dauzet MC, Broyer M, Rappaport R: Abnormal TSH, PRL and GH response to TSH releasing factor in chronic renal failure. J Clin Endocrinol Metab 43: 630-637, 1976
-
(1976)
J Clin Endocrinol Metab
, vol.43
, pp. 630-637
-
-
Czernichow, P.1
Dauzet, M.C.2
Broyer, M.3
Rappaport, R.4
-
5
-
-
0017091975
-
Thyroid function and metabolic state in chronic renal failure
-
Spector DA, Davis PJ, Helderman JH, Bell B, Utiger RD: Thyroid function and metabolic state in chronic renal failure. Ann Intern Med 85: 724-730, 1976
-
(1976)
Ann Intern Med
, vol.85
, pp. 724-730
-
-
Spector, D.A.1
Davis, P.J.2
Helderman, J.H.3
Bell, B.4
Utiger, R.D.5
-
6
-
-
0015348289
-
Free thyroxine in serum by equilibrium dialysis: Effects of dilution, specific ions and inhibitors of binding
-
Spaulding SW, Gregerman RI: Free thyroxine in serum by equilibrium dialysis: Effects of dilution, specific ions and inhibitors of binding. J Clin Endocrinol Metab 34: 974-982, 1972
-
(1972)
J Clin Endocrinol Metab
, vol.34
, pp. 974-982
-
-
Spaulding, S.W.1
Gregerman, R.I.2
-
7
-
-
33644807502
-
Low tri-iodothyronine: A new facet of inflammation in end-stage renal disease
-
Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F: Low tri-iodothyronine: A new facet of inflammation in end-stage renal disease. J Am Soc Nephrol 16: 2789-2795, 2005
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2789-2795
-
-
Zoccali, C.1
Tripepi, G.2
Cutrupi, S.3
Pizzini, P.4
Mallamaci, F.5
-
8
-
-
36248953130
-
Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease
-
Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR, Bárány P, Heimbürger O, Suliman ME, Alvestrand A, Lindholm B, Stenvinkel P: Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med 262: 690-701, 2007
-
(2007)
J Intern Med
, vol.262
, pp. 690-701
-
-
Carrero, J.J.1
Qureshi, A.R.2
Axelsson, J.3
Yilmaz, M.I.4
Rehnmark, S.5
Witt, M.R.6
Bárány, P.7
Heimbürger, O.8
Suliman, M.E.9
Alvestrand, A.10
Lindholm, B.11
Stenvinkel, P.12
-
9
-
-
2442539047
-
Correction of metabolic acidosis improves thyroid and growth hormone axes in hae-modialysis patients
-
Wiederkehr MR, Kalogiros J, Krapf R: Correction of metabolic acidosis improves thyroid and growth hormone axes in hae-modialysis patients. Nephrol Dial Transplant 19: 1190-1197, 2004
-
(2004)
Nephrol Dial Transplant
, vol.19
, pp. 1190-1197
-
-
Wiederkehr, M.R.1
Kalogiros, J.2
Krapf, R.3
-
10
-
-
78649799030
-
Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease
-
Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C: Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease. Am J Nephrol 33: 25-32, 2011
-
(2011)
Am J Nephrol
, vol.33
, pp. 25-32
-
-
Yilmaz, M.I.1
Sonmez, A.2
Karaman, M.3
Ay, S.A.4
Saglam, M.5
Yaman, H.6
Kilic, S.7
Eyileten, T.8
Caglar, K.9
Oguz, Y.10
Vural, A.11
Yenicesu, M.12
Zoccali, C.13
-
11
-
-
33748623395
-
Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease
-
Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P, Malatino LS, Bonanno G, Seminara G: Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. J Hypertens 24: 2039-2046, 2006
-
(2006)
J Hypertens
, vol.24
, pp. 2039-2046
-
-
Zoccali, C.1
Benedetto, F.2
Mallamaci, F.3
Tripepi, G.4
Cutrupi, S.5
Pizzini, P.6
Malatino, L.S.7
Bonanno, G.8
Seminara, G.9
-
12
-
-
33746634384
-
Low triiodothyronine and survival in end-stage renal disease
-
Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P: Low triiodothyronine and survival in end-stage renal disease. Kidney Int 70: 523-528, 2006
-
(2006)
Kidney Int
, vol.70
, pp. 523-528
-
-
Zoccali, C.1
Mallamaci, F.2
Tripepi, G.3
Cutrupi, S.4
Pizzini, P.5
-
13
-
-
0035864975
-
Thyroid hormone and the cardiovascular system
-
Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. N Engl J Med 344: 501-509, 2001
-
(2001)
N Engl J Med
, vol.344
, pp. 501-509
-
-
Klein, I.1
Ojamaa, K.2
-
14
-
-
41949107829
-
Acute effects of tri-iodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: A randomized, placebo-controlled study
-
Pingitore A, Galli E, Barison A, Iervasi A, Scarlattini M, Nucci D, L'abbate A, Mariotti R, Iervasi G: Acute effects of tri-iodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 93: 1351-1358, 2008
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 1351-1358
-
-
Pingitore, A.1
Galli, E.2
Barison, A.3
Iervasi, A.4
Scarlattini, M.5
Nucci, D.6
L'abbate, A.7
Mariotti, R.8
Iervasi, G.9
-
15
-
-
0032933702
-
Dangerous dogmas in medicine: The non-thyroidal illness syndrome
-
De Groot LJ: Dangerous dogmas in medicine: the non-thyroidal illness syndrome. J Clin Endocrinol Metab 84: 151-164, 1999
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 151-164
-
-
de Groot, L.J.1
-
16
-
-
41549117102
-
Observational research, randomised trials, and two views of medical science
-
Vandenbroucke JP: Observational research, randomised trials, and two views of medical science. PLoS Med 5: e67, 2008
-
(2008)
PLoS Med
, vol.5
-
-
Vandenbroucke, J.P.1
-
17
-
-
84857097187
-
Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients
-
Meuwese CL, Dekker FW, Lindholm B, Qureshi AR, Heimburger O, Barany P, Stenvinkel P, Carrero JJ: Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol 7: 131-138, 2012
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 131-138
-
-
Meuwese, C.L.1
Dekker, F.W.2
Lindholm, B.3
Qureshi, A.R.4
Heimburger, O.5
Barany, P.6
Stenvinkel, P.7
Carrero, J.J.8
-
18
-
-
0021829489
-
Protective adaptation of low serum triiodothyronine in patients with chronic renal failure
-
Lim VS, Flanigan MJ, Zavala DC, Freeman RM: Protective adaptation of low serum triiodothyronine in patients with chronic renal failure. Kidney Int 28: 541-549, 1985
-
(1985)
Kidney Int
, vol.28
, pp. 541-549
-
-
Lim, V.S.1
Flanigan, M.J.2
Zavala, D.C.3
Freeman, R.M.4
-
19
-
-
4544293443
-
Association of predialysis serum bicarbonate levels with risk of mortality and hospitaliza-tion in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
-
Bommer J, Locatelli F, Satayathum S, Keen ML, Goodkin DA, Saito A, Akiba T, Port FK, Young EW: Association of predialysis serum bicarbonate levels with risk of mortality and hospitaliza-tion in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44: 661-671, 2004
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 661-671
-
-
Bommer, J.1
Locatelli, F.2
Satayathum, S.3
Keen, M.L.4
Goodkin, D.A.5
Saito, A.6
Akiba, T.7
Port, F.K.8
Young, E.W.9
|